Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine versus bupropion for depressive episodes in bipolar II disorder
IRCT20200913048698N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Bipolar II disorder (BP-II) comparing Venlafaxine arm with Bupropion arm (2 arms). Primary endpoint: Treatment of depressive episode of bipolar II disorder. Started Dec 2020; status: completed.
02
Drugs
venlafaxinebupropion
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on IRCT20200913048698N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200913048698N1.